Renal Outcomes With Tenofovir Alafenamide in Liver Transplant Recipients

被引：3
|
作者：
Liu, Joanne K. [1 ]
Vutien, Philip [2 ]
Huang, Daniel Q. [3 ]
Ishigami, Masatoshi [4 ]
Landis, Charles S. [2 ]
Nguyen, Mindie H. [5 ,6 ]
机构：
[1] Univ Washington, Seattle, WA USA
[2] Hepatol Univ Washington, Div Gastroenterol, Seattle, WA USA
[3] Natl Univ Singapore, Natl Univ Hosp, Yong Loo Lin Sch Med, Div Gastroenterol & Hepatol,Dept Med, Singapore, Singapore
[4] Hepatol Nagoya Univ, Grad Sch Med, Div Gastroenterol, Nagoya, Japan
[5] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Palo Alto, CA USA
[6] Stanford Univ, Med Ctr, 780 Welch Rd, Palo Alto, CA 94304 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.cgh.2022.01.035
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：7
相关论文
共 50 条
  • [41] Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine Practice
    Toyoda, Hidenori
    Leong, Jennifer
    Landis, Charles
    Atsukawa, Masanori
    Watanabe, Tsunamasa
    Huang, Daniel Q.
    Liu, Joanne
    Quek, Sabrina Xin Zi
    Ishikawa, Toru
    Arai, Taeang
    Yokohama, Keisuke
    Chuma, Makoto
    Takaguchi, Koichi
    Uojima, Haruki
    Senoo, Tomonori
    Dang, Hansen
    Maeda, Mayumi
    Hoang, Joseph
    Le, Richard H.
    Yasuda, Satoshi
    Thin, Khin N.
    Tran, Sally
    Chien, Nicholas
    Henry, Linda
    Asai, Akira
    Fukunishi, Shinya
    Cheung, Ramsey
    Lim, Seng Gee
    Trinh, Huy N.
    Nguyen, Mindie H.
    HEPATOLOGY, 2021, 74 (02) : 656 - 666
  • [42] Tenofovir Use Is Not Associated with Reduced Bone Density or Fractures in Liver Transplant Recipients
    Lim, N.
    Engler, C.
    Lake, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 579 - 579
  • [43] TENOFOVIR ALAFENAMIDE VERSUS TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HEPATITIS B: LIVER- RELATED CLINICAL OUTCOMES AND SUBGROUP ANALYSIS BY LIVER CIRRHOSIS STATUS
    Kim, Soon Sun
    Seo, Gi Hyeon
    Han, Ji Eun
    Cho, Hyo Jung
    Kim, Eunju
    Yoon, Eileen
    Jang, Eun Sun
    Chang, Jong-In
    Cho, Young Youn
    Lee, Hyung Woong
    Cheong, Jae Youn
    Kim, Hyung Joon
    HEPATOLOGY, 2024, 80 : S168 - S168
  • [44] Clinical Outcomes in Renal Transplant Recipients With Fabry Disease
    Sandes-Freitas, T.
    Mata, G.
    Pinto, C.
    Custodio, L.
    Kirsztajn, G.
    Martins, A.
    Tedesco, H.
    Medina-Pestana, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 505 - 506
  • [45] Outcomes of invasive zygomycosis infections in renal transplant recipients
    Forrest, G. N.
    Mankes, K.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (02) : 161 - 164
  • [46] Renal histological lesions and outcome in liver transplant recipients
    Tsapenko, Mykola
    El-Zoghby, Ziad M.
    Sethi, Sanjeev
    CLINICAL TRANSPLANTATION, 2012, 26 (01) : E48 - E54
  • [47] Predictors of Renal Function in Pediatric Liver Transplant Recipients
    Elchaki, Rim
    Wilhalme, Holly
    Venick, Robert S.
    Laster, Marciana
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 601 - 602
  • [48] LIVER-DISEASE IN RENAL-TRANSPLANT RECIPIENTS
    SOPKO, J
    ANURAS, S
    AMERICAN JOURNAL OF MEDICINE, 1978, 64 (01): : 139 - 146
  • [49] Evaluation of renal and bone safety at 4 years in post-liver transplant patients with chronic kidney disease receiving Tenofovir Alafenamide for HBV prophylaxis
    Gane, Edward J.
    Dagooc, Rica
    Ray-Chaudhuri, Dominic
    Mules, Thomas
    Abramov, Frida
    Holt, Curtis
    Wang, Hongyuan
    Suri, Vithika
    Osinusi, Anu
    Flaherty, John F.
    JOURNAL OF HEPATOLOGY, 2022, 77 : S837 - S837
  • [50] LIVER-DISEASE IN RENAL-TRANSPLANT RECIPIENTS
    SHARMA, RK
    ELHENCE, R
    KHER, V
    NAIK, SR
    BHANDARI, M
    TRANSPLANTATION PROCEEDINGS, 1992, 24 (05) : 1915 - 1915
12345